Publish High Quality Research/Reviews Articles for just USD $99(+Taxes)
Animal Breeding & Genetics
2005-Current Professor, Department of Biochemistry, College of Medical Sciences, Nova Southeastern University, Ft. Lauderdale, FL
2017-Current Professor of Medical Education, College of Allopathic Medicine (CAM)
Nova Southeastern University, Ft. Lauderdale, FL
2015-2020 Research Affiliate Professor College of Sciences, Department of Chemistry and Biochemistry, Florida Atlantic University, Boca Raton, FL
2011 Professor of Biochemistry, College of Osteopathic Medicine, Nova Southeastern University, Ft. Lauderdale, FL
1999-2005 Associate Professor of Biochemistry, College of Medical Sciences, Nova Southeastern University, Ft. Lauderdale, FL
Genetics, Cellular and Molecular Biology
Dr.Sahar M.M. Omar now is a professor doctor at Ain Shams University and Armed Forces College of Medicine. She earned her B.Sc. in medicine, M.Sc.& Ph.D. in Histology & cell biology at Ain Shams University from 2000 to 2005. Dr. Sahar attended the BIT's 10th World Congress of Regenerative Medicine & Stem Cells -2016 in China and gave a talk titled as "Bone Marrow Mesenchymal Stem Cell Transplantation in a Rabbit Corneal Alkali Burn Model."Dr. Sahar possessed a strong publication record; she published a minireview titled“Superior Proliferative and Tissue Regeneration Potential of AdiposeTissue-Derived Mesenchymal Stem Cells Compared to BoneMarrow. It was published in Insights of stem cell journal Vol.1 No.1:7 (2015)http://stemcells.imedpub.com/. Dr. Sahar also published a minireview titled: Mesenchymal Stem Cells for Treating Ocular Surface Diseases in journal of stem cell research J Stem Cell Res. 2017; 1(1): 1-6.
Dr. Kulvinder Kaur is the Scientific Director of DR Kulvinder Kaur Centre for Human Reproduction, Jalandhar, Punjab, India, where she manages the complicated cases of infertility. She graduated from LHMC Delhi in 1980 topping in medicine in all 3 medical colleges thereby getting the DR Devi Chand Gold medal from the late PM Smt Indira Gandhi & also topped in all the MBBS subjects prior to that eg. anatomy, pathology, biochem etc making her basics sound &later she managed the endocrine clinic in PGI Chandigarh during her MD days .Following that she reported the 40th world case hydrometrocolpos working in Saudi Arabia &has been working in the field of neuroendocrinology of obesity.
GnRH control along with role of kisspeptins, prokineticins in human reproduction, AIDS & Cancer –during this period she managed to successfully treat the first case of nongestational choriocarcinoma of uterine body in a young girl medically thereby preserving her fertility-the first case in world literature of its kind.
Positions held: Bank manager, Financial
manager, Corporate Director
- Used to teach in various
Universities/Colleges in HCM City, Editors
of Scopus/ISI Journals
PUBLISHED MORE THAN
260-280 RESEARCH
ARTICLES ONLINE &
PRINT (ISI/SCOPUS, …)
2016 Doctor of Philosophy in Mathematics, D.Phil. The University of Sussex, Department of Mathematics, UK.
2010 Doctor of Philosophy in Economics, Ph.D., University of York. Department of Economics and Related Studies, UK.
2006 Master of Science, MSc. Economics University of York. Department of Economics and Related Studies, UK.
2005 PG. Dip. Statistics and Econometrics University of York. Department of Economics and Related Studies, UK.
2003 PG. Dip. Japanese Business Studies, Kansai Gaidai University, Faculty of International Business Studies, Osaka, Japan.
2004 Bachelor BSc. International Management, University of Applied Sciences Solothurn, Switzerland.
Versatile in Human Genetics, Pediatric Hematology, Medical Biostatistics and wide range of computer skills; data presentation and management.
Expanded Experience in the field of Family Genetics:
1. ADHD.
2. Autism, Autistic Disorders.
3. Children with Behavior Problems.
4. Disorder of Childhood and Adolescence.
Chien-Chang Lee, MD, ScD, is associate professor of emergency medicine at the National Taiwan University Hospital (NTUH). He severed as the deputy secretary general of Taiwan Society of Emergency and Critical Care Medicine, and deputy director of intelligent healthcare in NTUH. Dr. Lee is graduated from Harvard University and earned a doctoral degree in pharmacoepidemiology. Dr. Lee runs a Health Data Science lab, which consisted of 50 native or international students and research fellows around the world. Dr. Lee’s lab has rich experiences in evaluating the clinical value of new diagnostic tests. He pioneered in this field by introducing several new biomarkers and point-of-care multiplex PCR systems in Taiwan’s EM practice. He is also engaged in the development of artificial intelligence algorithm for decision support in the complicated environment of emergency medicine.
One of the most impactful findings of the lab is the discovery of the fatal cardiovascular complications, aortic dissection or aortic aneurysm rupture, associated with use of fluoquinolone antibiotics. Dr. Lee has extensive publications on infectious disease and epidemiology in several prestigious journals. His work also caused Food and Drug Administration of US to change the global fluoquinolone prescription guideline. Based on Dr. Lee’s work, the FDA recommends against the use of fluoquinolone in elderly patients with hypertension or peripheral vascular disease, or congenital collagen defect such as Marfan or Ehlers-Danos syndrome, unless there are no alternative antibiotics choices. The new guideline is expected to prevent thousands of incident aortic dissection or aortic aneurysm ruptures in the US alone. To date, professor Lee has published more than 180 scientific papers with more than 6000 citations (H-index 44).
Michel, Leclerc was born at St Benoit sur Loire (France)on 31/01/1941 Dr ès Sciences(Immunology, Cellular Biology,)
Last Position: Director of the Lab. Immunologie des Invertébrés, France.
Last research: Since 2010
I have discovered vaccination in Echinodermata by immunizations with various antigens (with or without Freund'adjuvant)
Prof. Ahmed Abdelmawla has received his PhD in the field of Pharmacognosy from Institute for Pharmaceutical Biology, Faculty of Pharmacy, Bonn University, Bonn, Germany. Currently, he is working as Professor of Pharmacognosy, Complementary and Alternative Medicine in Faculty of Pharmacy, Taif University, KSA. He has successfully completed his Administrative responsibilities as a head of Pharmacognosy Department, Faculty of Pharmacy, Taif University, KSA. His research has included: 1- Application of tissue culture techniques in production of biologically active secondary metabolites. 2- Complementary and Alternative Medicine. 3- Isolation, Identification, Structure Elucidation of Natural Products and Studying their Biological Activities. Based on this research and fellowship training he has received several awards and honors, such as: Taif University Award for Excellence in Research and Publishing Quality. He is serving as an editorial member of several reputed journals: 1- Spatula DD - Peer Reviewed Journal on Complementary Medicine and Drug Discovery. 2- Innovare Journal of Health Sciences. 3- Journal of Pharmacognosy (Bioinfo Publications). 4- International Journal of Chronic Diseases & Therapy (IJCDT). 5- Gavin Journal of Pharmaceutical and Pharmacological Sciences. 6- Jacobs Journal of Headache. 7- Open Access Journal of Pharmaceutical Research (OAJPR). 8- Madridge Journal of Novel Drug Research. 8- Future research in cancer and medicine.
He has authored 38 research articles/books. He is a member of Pharmacognosy Department, Faculty of Pharmacy, Assiut University, Assiut, Egypt.
Govind Hariharan is a Professor at Kennesaw State University and Board Chair and Faculty Advisor at the KSU Student Managed Investment Fund. He was previously the Executive Director of the India China America Institute and Chair of the Department of Economics and Finance at Kennesaw State University. He is also the founder of NEO Advisory LLC, a strategic advisory firm.
Govind Hariharan is a sought after advisor for his keen insights and has provided strategic advice on health care, technology, investments and global expansion to companies and governments. He serves or has served on many advisory boards including the Atlanta Society of Finance and Investment Professionals Foundation, Georgia Department of Revenue (until 2019), American Diabetes Association (until 2015), Georgia Indo American Chamber of Commerce (until 2015), and NCCSD (India). He has also served on the Boards of WellStar Institute for Better Health, and was a member of the WellStar- KSU Partnership Committee as well as various health care related task forces in Georgia and New York.. He has consulted for numerous organizations such as the World Bank and Council for Quality Growth.
Govind Hariharan is a sought after speaker at various venues such as the Global Leaders Forum, Wharton China Summit, Emory China Summit, Emory India Summit and TIE conferences on global expansion, investments, health care and entrepreneurship. He has been interviewed or quoted in many media outlets including the Financial Times, Investors Daily, O Globo, Atlanta Business Chronicle, Money Talks and National Public Radio.